Tell your friends about this item:
Practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours - IAEA human health series International Atomic Energy Agency
Do you have a profile? Log in
Get notified about new International Atomic Energy Agency releases
Add to your iMusic wish list
Practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours - IAEA human health series
International Atomic Energy Agency
Provides comprehensive multidisciplinary guidance to promote standardized, effective and safe implementation of best practices for treating neuroendocrine and gastroenteropancreatic tumours through applying peptide receptor radionuclide therapy (PRRNT).
134 pages, col. figs, tables